166 related articles for article (PubMed ID: 36289512)
1. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Johkoh T; Fujimoto K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Inomata M; Kamitani T; Yamazaki H; Ogawa Y; Yamamoto Y
Respir Res; 2022 Oct; 23(1):291. PubMed ID: 36289512
[TBL] [Abstract][Full Text] [Related]
2. Pulse versus non-pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Hyung K; Lee JH; Kim JY; Choi SM; Park J
Respirology; 2024 Mar; 29(3):235-242. PubMed ID: 38087838
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
[TBL] [Abstract][Full Text] [Related]
4. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
5. High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.
Arai T; Tachibana K; Sugimoto C; Inoue Y; Tokura S; Okuma T; Akira M; Kitaichi M; Hayashi S; Inoue Y
Respirology; 2017 Oct; 22(7):1363-1370. PubMed ID: 28508494
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
[TBL] [Abstract][Full Text] [Related]
7. Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
Sci Rep; 2021 Mar; 11(1):5782. PubMed ID: 33707613
[TBL] [Abstract][Full Text] [Related]
8. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
10. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
Cuerpo S; Moisés J; Hernández-González F; Benegas M; Ramirez J; Sánchez M; Agustí À; Sellares J
Chron Respir Dis; 2019; 16():1479973119869334. PubMed ID: 31431063
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study.
Atsumi K; Saito Y; Kuse N; Kobayashi K; Tanaka T; Kashiwada T; Inomata M; Kokuho N; Hayashi H; Kamio K; Fujita K; Abe S; Azuma A; Kubota K; Gemma A
Intern Med; 2018 Mar; 57(5):655-661. PubMed ID: 29151518
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
Jang HJ; Yong SH; Leem AY; Lee SH; Kim SY; Lee SH; Kim EY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
Sci Rep; 2021 Mar; 11(1):5762. PubMed ID: 33707643
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
18. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
